Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb/IIa receptor-mediated platelet aggregation

Journal of Clinical Investigation

Volumn 102, Issue 7, 1998, Pages 1301-1310

  Choudhri, Tanvir F ^a   Hoh, Brian L ^a   Zerwes, Hans Gunter ^b   Prestigiacomo, Charles J ^a   Kim, Samuel C ^a   Connolly Jr , E Sander ^a   Kottirsch, Georg ^b   Pinsky, David J ^a  

^a Columbia University ^*  (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Fibrin; GP IIb IIIa; Platelets; Stroke; Thrombosis

Indexed keywords

8 QUINOLINOL INDIUM IN 111; FIBRIN; FIBRINOGEN RECEPTOR ANTAGONIST; SDZ GPI 562; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; BLEEDING TIME; BRAIN HEMORRHAGE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MICROVASCULATURE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STROKE; THROMBOCYTE AGGREGATION INHIBITION; THROMBOSIS;

EID: 0032189318     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI3338     Document Type: Article

References (49)

1. del Zoppo, GJ., B.R. Copeland, L.A. Harker, T.A. Waltz, J. Zyroff, S.R. Hanson, and E. Battenberg. 1986. Experimental acute thrombotic stroke in baboons. Stroke. 17:1254-1265.
2. del Zoppo, G.J. 1994. Microvascular changes during cerebral ischemia and reperfusion. Cerebrovasc. Brain Metab. Rev. 6:47-96.
3. Okada, Y., B. Copeland, R. Fitridge, J.A. Koziol, and G.J. del Zoppo. 1994. Fibrin contributes to microvascular obstructions and parenchymal changes during early focal cerebral ischemia and reperfusion. Stroke. 25:1847-1854.
4. Connolly, E.S., Jr., C.J. Winfree, D.M. Stern, R.A. Solomon, and D.J. Pinsky. 1996. Procedural and strain-related variables significantly affect outcome in a murine model of focal cerebral ischemia. Neurosurgery. 38:523-532.
5. Connolly, E.S., Jr., C.J. Winfree, T.A. Springer, Y. Naka, H. Liao, S.D. Yan, D.M. Stern, R.A. Solomon, J-C. Gutierrez-Ramos, and D.J. Pinsky. 1996. Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. J. Clin. Invest. 97:209-216.
6. Connolly, E.S., Jr., C.J. Winfree, C.J. Prestigiacomo, S.C. Kim, T.F. Choudhri, B.L. Hoh, Y. Naka, R.A. Solomon, and D.J. Pinsky. 1997. Exacerbation of cerebral injury in mice which express the P-selectin gene: identification of P-selectin blockade as a new target for the treatment of stroke. Circ. Res. 81: 304-310.
7. Valles, J., M.T. Santos, A.J. Marcus, L.B. Safier, M.J. Broekman, N. Islam, H.L. Ullman, and J. Aznar. 1993. Downregulation of human platelet reactivity by neutrophils: participation of lipoxygenase derivatives and adhesive proteins. J. Clin. Invest. 92:1357-1365.
8. Lawson, C.A., S.-D. Yan, S.-F. Yan, H. Liao, G. Chen, J. Sobel, W. Kisiel, D.M. Stern, and D.J. Pinsky. 1997. Monocytes and tissue factor promote thrombosis in a murine model of oxygen deprivation. J. Clin. Invest. 99:1729-1738.
9. Ogawa, S., H. Gerlach, C. Esposito, A. Pasagian-Macaulay, J. Brett, and D.M. Stern. 1990. Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. J. Clin. Invest. 85:1090-1098.
10. Pinsky, DJ., M.C. Oz, S. Koga, Z. Taha, M.J. Broekman, A.J. Marcus, H. Liao, Y. Naka, J. Brett, P.J. Cannon, R. Nowygrod, T. Malinski, and D.M. Stern. 1994. Cardiac preservation is enhanced in a heterotopic rat transplant model by supplementing the nitric oxide pathway. J. Clin. Invest. 93:2291-2297.
11. Heye, N., C. Paetzold, R. Steinberg, and J. Cervos-Navarro. 1992. The topography of microthrombi in ischemic brain infarct. Acta Neurol. Scand. 86: 450-454.
12. Cortelazzo, S., G. Finazzi, M. Ruggeri, O. Vestri, M. Galli, F. Rodeghiero, and T. Barbui. 1995. Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis. N. Engl. J. Med. 332:1132-1136.
13. 111In-labeled platelet study. Stroke. 24:1534-1540.
14. Jafar, J.J., R. Menoni, H. Feinberg, G. LeBreton, and R.M. Crowell. 1989. Selective platelet deposition during focal cerebral ischemia in cats. Stroke. 20:664-667.
15. Obrenovitch, T.P., and J.M. Hallenbeck. 1985. Platelet accumulation in regions of low blood flow during the postischemic period. Stroke. 16:224-234.
16. Kochanek, P.M., A.J. Dutka, K.K. Kumaroo, and J.M. Hallenbeck. 1988. Effects of prostacyclin, indomethacin, and heparin on cerebral blood flow and platelet adhesion after multifocal ischemia of canine brain. Stroke. 19:693-699.
17. Bronner, L.L., D.S. Kanter, and J.E. Manson. 1995. Primary prevention of stroke. N. Engl. J. Med. 333:1392-1400.
18. Gryglewski, R.J., S. Nowak, E. Kostka-Trabka, J. Kusmiderski, A. Dembinska-Kiec, K. Bieron, M. Basista, and B. Blaszczyk. 1983. Treatment of ischaemic stroke with prostacyclin. Stroke. 14:197-202.
19. Bederson, J.B., L.H. Pitts, and M. Tsuji. 1986. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 17:412-476.
20. Kottirsch, G., H.-G. Zerwes, N.S. Cook, and C. Tapparelli. 1997. β amino acid derivatives as orally active non-peptide fibrinogen receptor antagonists. Bioorg. Med. Chem. Lett. 7:727-732.
21. Bowie, E.J.W., and C.A. Owen, Jr. 1974. The bleeding time. In Progress in Hemostasis and Thrombosis. T.H. Spaet, editor. Grune and Stratton, New York. 249-271.
22. Naka, Y., N.C. Chowdhury, H. Liao, D.K. Roy, M.C. Oz, R.E. Michler, and D.J. Pinsky. 1995. Enhanced preservation of orthotopically transplanted rat lungs by nitroglycerin but not hydralazine. Requirement for graft vascular homeostasis beyond harvest vasodilation. Circ. Res. 76:900-906.
23. Mizutani, H., T. Furubayashi, A. Kuriu, H. Take, Y. Tomiyama, H. Yoshida, Y, Nakamura, M. Inaba, T. Yonezawa, S. Tarui, and S. Ikehara. 1990. Analyses of thrombocytopenia in idiopathic thrombocytopenic purpura-prone mice by platelet transfer experiments between (NZW X BXSB)F1 and normal mice. Blood. 75:1809-1812.
24. Lahiri, B., J.A. Koehn, R.E. Canfield, S. Birken, and J. Lewis. 1981. Development of an immunoassay for the COOH-terminal region of the γ chains if human fibrin. Thromb. Res. 23:103-112.
25. Emeis, J.J., J. Lindeman, and W. Nieuwenhuizen. 1981. Immunoenzyme histochemical localization of fibrin degradation products in tissues. Am. J. Pathol. 103:337-344.
26. Choudhri, T.F., B.L. Hoh, R.A. Solomon, E.S. Connolly, Jr., and D.J. Pinsky. 1997. Use of a spectrophotometric hemoglobin assay to objectively quantify intracerebral hemorrhage in mice. Stroke. 28:2296-2302.
27. Cook, N.S., H.G. Zerwes, C. Tapparelli, M. Powling, J. Singh, R. Metternich, and A. Hagenbach. 1993. Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists. Thromb. Haemostasis. 70:531-539.
28. CAPRIE Steering Committee, 1997. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 348:1329-1339.
29. Willette, R.N., C.F. Sauermelch, R. Rycyna, S. Sarkar, G.Z. Feuerstein, A.J. Nichols, and E.H. Ohlstein. 1992. Antithrombotic effects of a platelet fibrinogen receptor antagonist in a canine model of carotid artery thrombosis. Stroke. 23:703-711.
30. Coller, B.S., J.D. Folts, S.R. Smith, L.E. Scudder, and R. Jordan. 1989. Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor. Correlation with bleeding time, platelet aggregation, and blockade of GPIIb/IIIa receptors. Circulation. 80: 1766-1774.
31. Zhang, Z., M. Chopp, R.L. Zhang, and A. Goussev. 1997. A mouse model of embolic focal cerebral ischemia. J. Cereb. Blood Flow Metab. 17:1081-1088.
32. Winfree, C.J., C.J. Baker, E.S. Connolly, Jr., A.J. Fiore, and R.A. Solomon. 1996. Mild hypothermia reduces penumbral glutamate levels in the rat permanent focal cerebral ischemia model. Neurosurgery. 38:1216-1222.
33. Fisher, M., P.H. Levine, A.L. Fullerton, A. Forsberg, C.P. Duffy, J.J. Hoogasian, and D.A. Drachman. 1982. Marker proteins of platelet activation in patients with cerebrovascular disease. Arch. Neurol. 39:692-695.
34. Iwamoto, T., H. Kubo, and M. Takasaki. 1995. Platelet activation in the cerebral circulation in different subtypes of ischemic stroke and Binswanger's disease. Stroke. 26:52-56.
35. Kooten, F.V., G. Ciabattoni, C. Patrono, P.I.M. Schmitz, J.V. Gijn, and P.J. Koudstaal. 1994. Evidence for episodic platelet activation in acute ischemic stroke. Stroke. 25:278-281.
36. Weiss, H.J., J. Hawiger, Z.M. Ruggeri, V.T. Turitto, P. Thiagarajan, and T. Hoffman. 1989. Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate. J. Clin. Invest. 83:288-297.
37. Hawiger, J. 1995. Mechanisms involved in platelet vessel wall interaction. Thromb. Haemostasis. 74:369-372.
38. Williams, M.J., X. Du, J. Loftus, and M.H. Ginsberg. 1995. Platelet adhesion receptors. Semin. Cell Biol. 6:305-314.
39. Parker, R.I., and H.R. Gralnick. 1986. Identification of platelet glycoprotein IIb/IIIa as the major binding site for released platelet von Willebrand factor. Blood. 68:732-736.
40. Robson, S.C., V.K. Young, N.S. Cook, G. Kottirsch, J.B. Siegel, B.A. Lesnokiski, D. Candinas, D.L.G. Wite, and F.H. Bach. 1996. Inhibition of platelet GPI IIb/IIIa in an ex vivo model of hyperacute xenograft rejection does not prolong cardiac survival. Xenotransplantation. 3:43-52.
41. Coller, B.S., K. Anderson, and H.F. Weisman. 1995. New antiplatelet agents: platelet GPIIb/IIIa antagonists. Thromb. Haemostasis. 74:302-308.
42. Willerson, J.T. 1996. Inhibitors of platelet glycoprotein IIb/IIIa receptors: will they be useful when given chronically? Circulation. 94:866-868.
43. Kotze, H.F., P.N. Badenhorst, S. Lamprecht, M. Meiring, V. Van Wyk, K. Nuyts, J.M. Stassen, J. Vermylen, and H. Deckmyn. 1995. Prolonged inhibition of acute arterial thrombosis by high dosing of a monoclonal anti-platelet glycoprotein IIb/IIIa antibody in a baboon model. Thromb. Haemostasis. 74: 751-757.
44. The EPIC Investigators, 1994. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N. Engl. J. Med. 330:956-961.
45. Tcheng, J.E., A.M. Lincoff, K.N. Sigmon, M.M. Kitt, R.M. Califf, E.J. Topol, and The IMPACT II Investigators. 1995. Platelet glycoprotein IIb/IIIa inhibition with Integrilin during percutaneous coronary intervention: the IMPACT II Trial. Circulation. 92:540-543.
46. The RESTORE (Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis) Investigators. 1997. Effects of platelet glycoprotein IIb/ IIIa blockade E with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Circulation. 96:1445-1453.
47. The EPILOG Investigators. 1997. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N. Engl. J. Med. 336:1689-1696.
48. Lincoff, A.M., and EPILOG Trial Group. 1996. Results of the interim analysis of the EPILOG trial. J. Am. Coll. Cardiol. 27:xxi.
49. Lind, S.E. 1991. The bleeding time does not predict surgical bleeding. Blood. 77:2547-2552.